- Home
- SRTS
as 03-25-2025 12:37pm EST
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | BOCA RATON |
| Market Cap: | 88.7M | IPO Year: | 2016 |
| Target Price: | $13.00 | AVG Volume (30 days): | 141.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.41 | EPS Growth: | 1266.06 |
| 52 Week Low/High: | $3.09 - $9.33 | Next Earning Date: | 05-08-2025 |
| Revenue: | $41,807,000 | Revenue Growth: | 71.31% |
| Revenue Growth (this year): | 9.09% | Revenue Growth (next year): | 22.30% |
Stock Insider Trading Activity of Sensus Healthcare Inc. (SRTS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Sardano Michael | SRTS | PRESIDENT AND GENERAL COUNSEL | Feb 10 '25 | Buy | $5.95 | 1,000 | $5,950.00 | 115,839 | |
| Rampolla Javier | SRTS | CHIEF FINANCIAL OFFICER | Feb 10 '25 | Buy | $5.95 | 501 | $2,980.95 | 40,745 |
Latest Sensus Healthcare Inc. News
SRTS Breaking Stock News: Dive into SRTS Ticker-Specific Updates for Smart Investing
Zacks
6 days ago
Here's Why Sensus Healthcare, Inc. (SRTS) Gained But Lagged the Market Today
Business Wire
12 days ago
Sensus Healthcare to Participate in the 37th Annual ROTH Conference
Simply Wall St.
12 days ago
Impressive Earnings May Not Tell The Whole Story For Sensus Healthcare (NASDAQ:SRTS)
Simply Wall St.
13 days ago
Sensus Healthcare Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
Zacks
18 days ago
Brokers Suggest Investing in Sensus Healthcare (SRTS): Read This Before Placing a Bet
Business Wire
19 days ago
Sensus Healthcare to Showcase Commercial and Late-Stage Products at the American Academy of Dermatology Annual Meeting
Simply Wall St.
21 days ago
Sensus Healthcare (NasdaqCM:SRTS) Shares Dip 14% After Q4 Earnings Show US$3 Million Net Income Drop
Business Wire
21 days ago
Sensus Healthcare Announces Publication of Study at Tri Service Military Hospital in Taiwan Demonstrating Efficacy of SRT-100® in Preventing Keloid Recurrence
Compare SRTS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SRTS Sensus Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.